Evidence map›Paper›PMID 40049934›Full record

ArticleJACC. Asia2025

A Multicenter Feasibility and Safety Study of a Novel Hybrid IVUS-OCT Imaging System.

Qinhua Jin, Zhenhong Fu, Yupeng Wang, Yong Zeng, Xiaoling Zhang, Yicong Ye, Yida Tang, Xinye Xu, Yundai Chen

Registry-linked trialAbstract read
In one paragraph

Article in JACC. Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04617899 (The Study to Evaluate the Performance and Safety of the Novasight Hybrid System Using Objective Performance Criteria), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04617899 naunknown statusnot on this map

The Study to Evaluate the Performance and Safety of the Novasight Hybrid System Using Objective Performance Criteria

TypeinterventionalSponsorCardioNavi MedTech (Wuhan) Co., Ltd.Ran2021 to 2021Enrolled120ConditionsCoronary Artery DiseaseArmsIntravascular imaging
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qinhua JinDepartment of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China.
Zhenhong FuDepartment of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China.
Yupeng WangDepartment of Cardiology, Peking University Third Hospital, Beijing, China.
Yong ZengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoling ZhangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yicong YeDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yida TangDepartment of Cardiology, Peking University Third Hospital, Beijing, China.
Xinye XuDepartment of Cardiology, Peking University Third Hospital, Beijing, China.
Yundai ChenDepartment of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China. Electronic address: cyundai@vip.163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, precise stent manipulation and placement in percutaneous coronary intervention remain compromised. Intravascular imaging techniques are often limited by either spatial resolution or depth of penetration. A hybrid intravascular ultrasound (IVUS)-optical coherence tomography (OCT) system would be a better choice for interventional cardiologists. To validate the image quality and safety of the novel IVUS-OCT system for guiding coronary intervention in Chinese patients, a total of 114 cases were included. The proportion of clear imaging length was 96.21% ± 10.16%. Device success rate was 99.1%, technical success rate was 98.2%, and excellent image rate was 96.5%. No catheter-related adverse events occurred, and the incidence of device defects was 0.9%. This study preliminarily verified the image quality and safety of the novel Hybrid IVUS and OCT imaging system. (The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria [SUPERIOR]; NCT04617899).

Indexed as

coronary arteriosclerosishybrid intravascular imagingintravascular ultrasoundmultimodality intravascular imagingoptical coherence tomography

Identifiers

PMID40049934
PMCPMC11934039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.